Experimental and Clinical Applications of Chamaecyparis obtusa Extracts in Dry Eye Disease

Table 3

Schirmer’s test value in the treatment and placebo groups at baseline, 2 weeks, and 4 weeks after treatment.

	Follow-up periods			value
	Baseline	2 weeks	4 weeks	1	2	3
Treatment group ()	6.84 ± 1.03	6.92 ± 0.91	7.04 ± 1.49	0.99	0.98	0.98
Placebo group ()	6.56 ± 1.16	6.64 ± 1.08	6.91 ± 1.29	0.99	0.84	0.99
P value	0.50	0.42	0.87

1 baseline versus 2 weeks; 2 baseline versus4 weeks; and 3 2 weeks versus 4 weeks.